Related Articles
Therapeutic efficacy of intra‑tumor AvidinOX and low systemic dose biotinylated cetuximab, with and without cisplatin, in an orthotopic model of head and neck cancer
Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties
Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines
Adenovirus-mediated p53 gene therapy in nasopharyngeal cancer
In vitro assessment of the role of DpC in the treatment of head and neck squamous cell carcinoma